Leishmaniasis 1 Leishmaniasis Species Pathogenic in Humans Leishmania



























- Slides: 27
Leishmaniasis 1
Leishmaniasis Species Pathogenic in Humans Leishmania donovani (complex) (VL) Leishmania tropica (CL) Leishmania major (CL) Leishmania aethiopica (CL) Leishmania mexicana (Complex) (CL) Leishmania brazilliensis (complex) (MCL) 2
The Parasite • Phylum Sarcomastigophora • Order Kinetoplastida • Family Trypanosomatidae • Genus Leishmania 3
Morphology Digenetic Life Cycle • Promasitogte • Insect • Motile • Midgut • Amastigote • Mammalian stage • Non-motile • Intracellular 4
Morphology • Promastigote • Amastigote Flagella Kinetoplast Golgi Nucleus Cytoskeleton 5
Promastigote 6
Amastigote 7
• Leishmania (Leishman. Donovan or LD bodies). Lying in macrophage cells from liver. Giemsa. × 12000. Enlarged by 9. 6. 8
• A macrophage filled with Leishmania amastigotes. 9
Life cycle • The organism is transmitted by the bite of several species of blood-feeding sand flies (Phlebotomus) which carries the promastigote in the anterior gut and pharynx • Dogs and rodents are common reservoirs. 10
11
Mammalian Hosts • Rodents • Bats • Dogs • Foxes 12
Vectors Phlebotomine Sandflies 13
14
Clinical Disease • Visceral • Fatal (90% untreated) • Liver • Spleen • Bone marrow • Cutaneous • Generally Self- healing • Skin • Mucous membranes SPECTRUM OF DISEASE 15
Initial Infection • • Similar in all species Inoculation of promastigotes Inflammation & chemotaxis Receptor mediated phagocytosis Promastigote Amasitgote Transformation 16
Parasite Spread Macrophage lysis & parasite release Lymphatic spread Blood spread Target organs Skin/lymph nodes/spleen/liver/ bone marrow 17
Clinical Manifestation Variable - Incubation 3 -100+ weeks Lowgrade fever Hepato-splenomegaly Bone marrow hyperplasia Anemia, Leucopenia & Cachexia Hypergammaglobulinnemia Epistaxis , Proteinuria, Hematuria 18
• A boy suffering from visceral leishmaniasis. The boy exhibits splenomegaly, distended abdomen and severe muscle wasting. 19
• Jaundiced hands of a visceral leishmaniasis patient. 20
• Enlarged spleen and liver in an autopsy of an infant dying of visceral leishmaniasis. 21
Post Kala Azar Dermal Leishmanoid Normally develops <2 years after recovery Recrudescence Restricted to skin Rare but varies geographically 22
Cutaneous leishmaniasis of the face. 23
A cutaneous leishmaniasis lesion on the arm. 24
INFECTION Sub-clinical or inapparent infection Recovery Death Immune to reinfection Concurrent infection PKDL 25
Diagnosis Bone marrow biopsy Spleen or liver biopsy Culture & Histology 26
Treatment Pentavalent antimony Pentamidine New drugs - New delivery 27